The Scientific Advisors at Elevian provide expert guidance and insight into the development of regenerative medicines aimed at addressing aging mechanisms. This team, composed of leading scientists and clinical advisors, collaborates to shape research strategies, validate scientific approaches, and ensure clinical relevance, particularly in stroke and other age-related conditions. Their collective expertise drives innovation and positions Elevian at the forefront of regenerative medicine advancements.
Amy Wagers
Scientific Co-Founder
Daniel Laskowitz
Stroke Advisor
David Lin
Stroke Clinical Advisory Board
Lee Rubin
Scientific Co-Founder
Orit Foord
Antibody Program Advisor
Rich Lee
Scientific Co-Founder
Ryan Walker
Scientific Co-Founder
Seth Finklestein
Stroke Clinical Advisory Board
Steven Cramer
Stroke Clinical Advisory Board
Teresa Kimberley
Stroke Clinical Advisory Board
View all